Assessment of Probability of Pulmonary Fibrosis Progression in Patients with Interstitial Lung Diseases to Determine Further Treatment Tactics

Assessment of Probability of Pulmonary Fibrosis Progression in Patients with Interstitial Lung Diseases to Determine Further Treatment Tactics

The objective: to develop a method for assessing the probability of progression of pulmonary fibrosis in patients with interstitial lung diseases in order to determine further treatment tactics.Subjects and Methods. 80 patients with interstitial lung diseases underwent lung biopsies with consequent...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. A. Lukashevich, O. A. Yudina, L. S. Bogush, E. I. Davidovskaya, M. I. Dyusmikeeva, A. F. Belko
Format:	Article
Language:	Russian
Published:	New Terra Publishing House 2024-07-01
Series:	Туберкулез и болезни лёгких
Subjects:	interstitial lung diseases progression of lung fibrosis morphological tests immunohistochemical test probability prediction
Online Access:	https://www.tibl-journal.com/jour/article/view/1813
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Computed tomography in evaluating the development of different types of pulmonary fibrosis in patients with interstitial lung diseases
by: A. A. Speranskaya, et al.
Published: (2016-03-01)

Interstitial lung diseases: a view on the problem
by: O. G. Sych, et al.
Published: (2025-06-01)

Predicting biomarkers of progressive pulmonary fibrosis: morphological, cytokine profile, and clinical portrait
by: Nicol Bernardinello, et al.
Published: (2025-06-01)

Forced oscillation technique in progressive pulmonary fibrosis in a single-center retrospective study
by: A. Denis, et al.
Published: (2025-05-01)

Epidemiology and Prognosis of Progressive Pulmonary Fibrosis: A Literature Review
by: Ignacio Español Montero, et al.
Published: (2025-06-01)

Peripheral and pulmonary telomere lengths in patients with non-idiopathic pulmonary fibrosis interstitial lung diseases
by: Yujie Shi, et al.
Published: (2025-08-01)

Long-Term Follow-Up of Interstitial Lung Abnormalities in Low-Dose Chest CT in Health Screening: Exploring the Predictors of Clinically Significant Interstitial Lung Diseases Using Artificial Intelligence-Based Quantitative CT Analysis
by: Won Jong Jeong, et al.
Published: (2024-11-01)

Serum inflammatory markers as predictors of therapeutic response in non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease: a retrospective cohort analysis
by: Yanisa Kluanwan, et al.
Published: (2025-05-01)

Development and evaluation of a questionnaire to capture environmental and occupational inhalational exposures in adults with fibrotic interstitial lung disease
by: Aparna C Swaminathan, et al.
Published: (2024-10-01)

Biomarkers of interstitial lung disease in systemic scleroderma and their significance
by: D. V. Khorolsky, et al.
Published: (2023-02-01)

Drug-Induced Interstitial Lung Disease
by: Wei-I Lee, et al.
Published: (2019-01-01)

Neutrophils and Lymphocytes: Yin and Yang of Lung Fibrosis and Patient Outcome in Diffuse Interstitial Lung Diseases
by: Erika M. Novoa-Bolivar, et al.
Published: (2024-10-01)

DNA methylome biomarkers of rheumatoid arthritis-associated interstitial lung disease reflecting lung fibrosis pathways, an exploratory case–control study
by: Bartosz Kaczmarczyk, et al.
Published: (2025-04-01)

Validation of the gender, age, physiology model and other prognostic factors in interstitial lung disease patients with systemic autoimmune rheumatic disease
by: Yun Jung Hwang, et al.
Published: (2025-07-01)

The role of lung cancer in mortality rate in chronic fibrosing idiopathic interstitial pneumonia
by: Beatriz Morales Chacón, et al.
Published: (2025-05-01)

Assessment and follow-up of interstitial lung disease
by: Devarasetti Phani Kumar
Published: (2021-01-01)

Myeloperoxidase‐Antibody Positivity and Progression to Microscopic Polyangiitis in Interstitial Lung Disease: A Case Series
by: Michael Hoskins, et al.
Published: (2025-07-01)

Predictive Biomarkers and Novel Treatments for the Progressive Fibrosing Phenotype in Interstitial Lung Disease Associated with Connective Tissue Disease
by: Sang Wan Chung
Published: (2025-06-01)

Clustering-aided prediction of outcomes in patients with idiopathic pulmonary fibrosis
by: Lijun Wang, et al.
Published: (2024-10-01)

Study Design and Rationale for the TETON-PPF Phase 3, Randomized, Controlled Clinical Trial of Inhaled Treprostinil in the Treatment of Progressive Pulmonary FibrosisTake-Home Points
by: Steven D. Nathan, MD, et al.
Published: (2025-06-01)

Bronchoalveolar Lavage Derived Fibroblasts From Interstitial Lung Disease Patients: A Chance to Exploit 2D/3D Model of Pulmonary Fibrosis In Vitro
by: Paolo Giannoni, et al.
Published: (2025-07-01)

Lung transplantation for connective tissue disease–related interstitial lung disease: Clinical outcomes compared to idiopathic pulmonary fibrosis
by: Sarah L. Khan, MD, MHS, et al.
Published: (2025-08-01)

Alveolar cell composition in interstitial lung disease and the development of a pulmonary progressive fibrosing phenotype: a retrospective cohort study
by: Iris A. Simons, et al.
Published: (2025-04-01)

Impact of Air Pollution on the Long-Term Decline of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease
by: Pablo Mariscal-Aguilar, et al.
Published: (2024-11-01)

Interstitial lung disease in systemic sclerosis (systemic scleroderma)
by: L. P. Ananyeva, et al.
Published: (2021-03-01)

Prognostic significance of acute exacerbations and usual interstitial pneumonia in fibrotic interstitial lung disease
by: Yun Zhang, et al.
Published: (2025-07-01)

Prevalence and clinical features of interstitial lung disease in patients with psoriasis
by: Nobuhiro Kanaji, et al.
Published: (2024-12-01)

Frequency of imaging phenotypes of pulmonary interstitial fibrosis
by: Wallace T. Miller Jr, et al.
Published: (2025-05-01)

Radiological and Clinical Presentation of Interstitial Lung Disease in Patients with Concomitant Psoriasis: A Cross-sectional Study
by: Manoj Meena, et al.
Published: (2025-04-01)

Determinants for worsening in systemic autoimmune rheumatic disease-associated interstitial lung disease: a systematic review and meta-analysis of cohort studies
by: Jiaheng Yao, et al.
Published: (2024-11-01)

What do we know about extracellular vesicles in patients with idiopathic pulmonary fibrosis? a scoping review
by: Maria Conti, et al.
Published: (2025-07-01)

Integrating Radiomics Signature into Clinical Pathway for Patients with Progressive Pulmonary Fibrosis
by: Giacomo Sica, et al.
Published: (2025-01-01)

Single lung transplantation for pulmonary fibrosis: Does side matter?
by: Frank Langer, et al.
Published: (2025-05-01)

The patient journey and burden of disease in progressive pulmonary fibrosis in Japan: a cross-sectional survey
by: Yuko Kaneko, et al.
Published: (2025-04-01)

Idiopathic Pulmonary Fibrosis, Today and Tomorrow: Certainties and New Therapeutic Horizons
by: Giacomo Giulianelli, et al.
Published: (2025-05-01)

Esophageal Diameter on High-Resolution Computed Tomography – a Potential Useful Marker for Interstitial Lung Disease Severity in Patients with Systemic Sclerosis
by: Anja Ljilja Posavec, et al.
Published: (2024-01-01)

Quantitative analysis of pathological findings identified clinical heterogeneity in nonspecific interstitial pneumonia with organising pneumonia overlap
by: Masato Asaoka, et al.
Published: (2025-06-01)

Protocol and research program of the European registry and biobank for interstitial lung diseases (eurILDreg)
by: Ekaterina Krauss, et al.
Published: (2024-11-01)

Diagnosis, screening, and follow-up of patients with familial interstitial lung disease: Results from an international survey
by: Emil Vilstrup Moen, et al.
Published: (2025-02-01)

Unveiling the radiological odyssey: Navigating the interstitial with artificial intelligence
by: Anna Russo, et al.
Published: (2024-11-01)